바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev Next
e-Submission

Vol.61 No.5
Citation Share

Clinical Significance of Methacholine Bronchial Challenge Test in Differentiating Asthma from COPD

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2006, v.61 no.5, pp.433-439









& (2006). Clinical Significance of Methacholine Bronchial Challenge Test in Differentiating Asthma from COPD. Tuberculosis & Respiratory Diseases, 61(5), 433-439.
  • Downloaded
  • Viewed
PDF Download

Abstract

Background: Although airway hyper-responsiveness is one of the characteristics of asthma. bronchial hyper-responsiveness has also been observed to some degree in patients with chronic obstructive pulmonary disease (COPD). Moreover, several reports have demonstrated that a number of patients have both COPD and asthma. The methacholine bronchial challenge test (MCT) is a widely used method for the detecting and quantifying the airway hyper- responsiveness, and is one of the diagnostic tools in asthma. However, the significance of MCT in differentiating asthma or COPD combined with asthma from pure COPD has not been defined. The aim of this study was to determine the role of MCT in differentiating asthma from pure COPD. Method: This study was performed prospectively and was composed of one hundred eleven patients who had undergone MCT at Chonbuk National University Hospital. Sixty-five asthma patients and 23 COPD patients were enrolled and their MCT data were analyzed and compared with the results of a control group. Result: The positive rates of MCT were 65%, 30%, and 9% in the asthma, COPD, and control groups, respectively. The mean PC20 values of the asthma, COPD, and control groups were 8.1±1.16 mg/mL, 16.9±2.21 mg/mL, and 22.0±1.47 mg/mL, respectively. The sensitivity, specificity, positive predictive value, and negative predictive value of MCT for diagnosing asthma were 65%, 84%, 81%, and 69%, respectively. The sensitivity, specificity, positive predictive value, and negative predictive value of MCT (ed note: please check this as I believe that these values correspond to the one PC20 value. Please check my changes.) at the new cut-off points of PC20 ≤ 16 mg/ml, were 80%, 75%, 78%, and 78%, respectively. Conclusion: MCT using the new cut-off point can be used as a more precise and useful diagnostic tool for distinguishing asthma from pure COPD. (Tuberc Respir Dis 2006; 61: 433-439)

keywords
Bronchial challenge test, COPD, Asthma., Bronchial challenge test, COPD, Asthma.

Reference

1.

(2004) National clinical guideline on management of chronic obstructive pulmonary disease in adult in primary and secondary care,

2.

(2004) Mecahnisms of bronchial hyperreactivity in asthmaand chronic obstructive pulmonary disease,

3.

(1987) Descriptive epidemiology of bronchial reactivity in an adult population:results from a community study,

4.

(1994) Factors influencing the occurrence of airway hyperreactivity in the general population:the importance of atopy and airway caliber,

5.

(thorax198742) Prevalence of bronchial hyperresponsiveness and asthma in a rural adult population,

6.

(2002) Risk factors for bronchial hyperresponsiveness in late childhood and early adolescence,

7.

(1994) Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma,

8.

(1992) The lung health study:airway responsiveness to inhaledmethacholin in smokers with mild to moderate airflow limitation,

9.

(2000) Guidelines for methacholine and exercise challenge testing-1999: this official statement of the American thoracic society was adopted by the ATS board of directors, July 1999,

10.

(1987) The relationship of nonspecific bronchial responsiveness to the occurrence of respiratory symptoms and decreased levels of pulmonary function:the Normative Aging Study,

11.

(1985) Bronhcial reactivity to inhaled histamine and annual rate of decline in FEV1 in male smokers and ex-smoker,

12.

(2003) Prevalence of combined bronchial asthma with COPD in patients with moderate to severe air flow limitation,

13.

(2004) Physiologic similarities and differences between COPD and asthma,

14.

(2000) Obstructive lung disease and low lung function in adults in the United States data from the National Health and Nutrition Examination Survey,

15.

(2003) Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease,

16.

(Med1985) Evaluation of clinical significance of methacholine challenge test in asthma,allergic rhinitis,and chest symptom patients,

17.

(1982) Bronchial hyperreactivity in chronic obstructive bronchitis,

18.

(1984) Nonallergic bronchial hyperexcitability in chronic bronchitis,

19.

(1985) Prevalence and nature of bronchial hyperresponsiveness in subjects with chronic obstructive pulmonary disease,

20.

(1988) Airway responsiveness to inhaled histamine in chronic obstructive airway disease:chronic bronchitis versus emphysema,

21.

(amrevrespirdis1993148) Long term-variability of bronchial responsiveness to histamine in a random population sample of adults,

22.

(chest1993104) Diagnostic value of the bronchial provocation test with methacholine in asthma,

Tuberculosis & Respiratory Diseases

e-Submission OA Policy